Amlodipine/Atorvastatin/Candesartan

氨氯地平/阿托伐他汀/坎地沙坦

Report date: 2024/11/23 20:00:08

Base Information

Drug NameAmlodipine/Atorvastatin/Candesartan

Drug Alias Name坎地沙坦/阿托伐他汀/氨氯地平Amlodipine/Candesartan/AtorvastatinAtorvastatin/Amlodipine/Candesartan阿托伐他汀/氨氯地平/坎地沙坦Candesartan/Amlodipine/Atorvastatin +[15]

ClassificationSmall molecules

Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersHMG-CoA reductase inhibitors

TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelHMG-CoA reductase

Therapy Area/IndicationsDyslipidemiasHypertensionCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsYes Candesartan Cilexetil Amlodipine Besylate Atorvastatin Calcium Hydrate

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesChong Kun Dang Pharmaceutical Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesChong Kun Dang Pharmaceutical Corp

Active IndicationsN/A

Inactive IndicationsDyslipidemiasHypertensionCardiovascular Diseases

Other Information

ATC CodeN/A